Topical Ruxolitinib Effective for Vitiligo in Adolescents Topical Ruxolitinib Effective for Vitiligo in Adolescents

Ruxolitinib cream is under review at the US Food and Drug Administration for treating vitiligo in patients ages 12 years and older; the agency is expected to make a decision by July 18.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news